{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:33:53Z","timestamp":1794011633190,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A5A1011974"],"award-info":[{"award-number":["2016R1A5A1011974"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C3004586"],"award-info":[{"award-number":["2021R1A2C3004586"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Valvular inflammation triggered by hyperlipidemia has been considered as an important initial process of aortic valve disease; however, cellular and molecular evidence remains unclear. Here, we assess the relationship between plasma lipids and valvular inflammation, and identify association of low-density lipoprotein with increased valvular lipid and macrophage accumulation. Single-cell RNA sequencing analysis reveals the cellular heterogeneity of leukocytes, valvular interstitial cells, and valvular endothelial cells, and their phenotypic changes during hyperlipidemia leading to recruitment of monocyte-derived MHC-II<jats:sup>hi<\/jats:sup> macrophages. Interestingly, we find activated PPAR\u03b3 pathway in <jats:italic>Cd36<\/jats:italic><jats:sup>+<\/jats:sup> valvular endothelial cells increased in hyperlipidemic mice, and the conservation of PPAR\u03b3 activation in non-calcified human aortic valves. While the PPAR\u03b3 inhibition promotes inflammation, PPAR\u03b3 activation using pioglitazone reduces valvular inflammation in hyperlipidemic mice. These results show that low-density lipoprotein is the main lipoprotein accumulated in the aortic valve during hyperlipidemia, leading to early-stage aortic valve disease, and PPAR\u03b3 activation protects the aortic valve against inflammation.<\/jats:p>","DOI":"10.1038\/s41467-022-33202-2","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:05:40Z","timestamp":1663412740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPAR\u03b3 during hyperlipidemia"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4876-0477","authenticated-orcid":false,"given":"Seung Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-750X","authenticated-orcid":false,"given":"Nayoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-744X","authenticated-orcid":false,"given":"Minkyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ho","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inhee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongdae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahee","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du-Min","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Kee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-3977","authenticated-orcid":false,"given":"Seung-Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4423-5122","authenticated-orcid":false,"given":"Jongsuk","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-4389","authenticated-orcid":false,"given":"Ki-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-jin","family":"Ann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Suk","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Cheol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-1698","authenticated-orcid":false,"given":"Goo Taeg","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4234-0380","authenticated-orcid":false,"given":"Woong-Yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-0322","authenticated-orcid":false,"given":"Hae-Ock","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-3463","authenticated-orcid":false,"given":"Jae-Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"33202_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cjca.2014.03.022","volume":"30","author":"B Iung","year":"2014","unstructured":"Iung, B. & Vahanian, A. Epidemiology of acquired valvular heart disease. Can. J. Cardiol. 30, 962\u2013970 (2014).","journal-title":"Can. J. Cardiol."},{"key":"33202_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","volume":"141","author":"S Yadgir","year":"2020","unstructured":"Yadgir, S. et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017. Circulation 141, 1670\u20131680 (2020).","journal-title":"Circulation"},{"key":"33202_CR3","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck, M. R., Boon, N. A. & Newby, D. E. Calcific aortic stenosis: a disease of the valve and the myocardium. J. Am. Coll. Cardiol. 60, 1854\u20131863 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJMra1313875","volume":"371","author":"CM Otto","year":"2014","unstructured":"Otto, C. M. & Prendergast, B. Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction. N. Engl. J. Med. 371, 744\u2013756 (2014).","journal-title":"N. Engl. J. Med."},{"key":"33202_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon, M. B. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597\u20131607 (2010).","journal-title":"N. Engl. J. Med."},{"key":"33202_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ejcts.2006.07.028","volume":"30","author":"P Varadarajan","year":"2006","unstructured":"Varadarajan, P., Kapoor, N., Bansal, R. C. & Pai, R. G. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur. J. Cardiothorac. Surg. 30, 722\u2013727 (2006).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"33202_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrcardio.2014.1","volume":"11","author":"JD Hutcheson","year":"2014","unstructured":"Hutcheson, J. D., Aikawa, E. & Merryman, W. D. Potential drug targets for calcific aortic valve disease. Nat. Rev. Cardiol. 11, 218\u2013231 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"33202_CR8","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1161\/ATVBAHA.120.315261","volume":"40","author":"JC Grim","year":"2020","unstructured":"Grim, J. C. et al. Secreted factors from proinflammatory macrophages promote an osteoblast-like phenotype in valvular interstitial cells. Arterioscler. Thromb. Vasc. Biol. 40, e296\u2013e308 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR9","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2015.09.087","volume":"66","author":"GR Ten Kate","year":"2015","unstructured":"Ten Kate, G. R. et al. Increased aortic valve calcification in familial hypercholesterolemia: prevalence, extent, and associated risk factors. J. Am. Coll. Cardiol. 66, 2687\u20132695 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/gim.2017.151","volume":"20","author":"JR Chora","year":"2018","unstructured":"Chora, J. R., Medeiros, A. M., Alves, A. C. & Bourbon, M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet. Med. 20, 591\u2013598 (2018).","journal-title":"Genet. Med."},{"key":"33202_CR11","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1210\/jc.2016-1206","volume":"101","author":"A Langsted","year":"2016","unstructured":"Langsted, A., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A. & Kamstrup, P. R. PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis. J. Clin. Endocrinol. Metab. 101, 3281\u20133287 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"33202_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","volume":"5","author":"N Perrot","year":"2020","unstructured":"Perrot, N. et al. Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis. JACC Basic Transl. Sci. 5, 649\u2013661 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"33202_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan, K. L. et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 121, 306\u2013314 (2010).","journal-title":"Circulation"},{"key":"33202_CR14","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell, S. J. et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352, 2389\u20132397 (2005).","journal-title":"N. Engl. J. Med."},{"key":"33202_CR15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","volume":"359","author":"AB Rossebo","year":"2008","unstructured":"Rossebo, A. B. et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359, 1343\u20131356 (2008).","journal-title":"N. Engl. J. Med."},{"key":"33202_CR16","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","volume":"41","author":"M Nazarzadeh","year":"2020","unstructured":"Nazarzadeh, M. et al. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. Eur. Heart J. 41, 3913\u20133920 (2020).","journal-title":"Eur. Heart J."},{"key":"33202_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1084\/jem.20082129","volume":"206","author":"JH Choi","year":"2009","unstructured":"Choi, J. H. et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497\u2013505 (2009).","journal-title":"J. Exp. Med."},{"key":"33202_CR18","doi-asserted-by":"crossref","unstructured":"Hulin A, et al. Maturation of heart valve cell populations during postnatal remodeling. Development 146, dev173047 (2019).","DOI":"10.1242\/dev.173047"},{"key":"33202_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2019.01.021","volume":"48","author":"A Shigeta","year":"2019","unstructured":"Shigeta, A. et al. Endocardially derived macrophages are essential for valvular remodeling. Dev. Cell 48, 617\u2013630.e613 (2019).","journal-title":"Dev. Cell"},{"key":"33202_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.118.312804","volume":"123","author":"K Kim","year":"2018","unstructured":"Kim, K. et al. Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models. Circ. Res. 123, 1127\u20131142 (2018).","journal-title":"Circ. Res."},{"key":"33202_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0022-2275(20)32566-9","volume":"39","author":"D Calvo","year":"1998","unstructured":"Calvo, D., Gomez-Coronado, D., Suarez, Y., Lasuncion, M. A. & Vega, M. A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39, 777\u2013788 (1998).","journal-title":"J. Lipid Res."},{"key":"33202_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","volume":"569","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature 569, 565\u2013569 (2019).","journal-title":"Nature"},{"key":"33202_CR23","doi-asserted-by":"publisher","first-page":"12938","DOI":"10.1074\/jbc.272.20.12938","volume":"272","author":"M Lougheed","year":"1997","unstructured":"Lougheed, M. et al. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I\/II. J. Biol. Chem. 272, 12938\u201312944 (1997).","journal-title":"J. Biol. Chem."},{"key":"33202_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2016.06.011","volume":"251","author":"C Goettsch","year":"2016","unstructured":"Goettsch, C. et al. A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification. Atherosclerosis 251, 109\u2013118 (2016).","journal-title":"Atherosclerosis"},{"key":"33202_CR25","doi-asserted-by":"crossref","unstructured":"Chakarov, S. et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science 363, eaau0964 (2019).","DOI":"10.1126\/science.aau0964"},{"key":"33202_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCULATIONAHA.118.038362","volume":"140","author":"AS Kalluri","year":"2019","unstructured":"Kalluri, A. S. et al. Single-cell analysis of the normal mouse aorta reveals functionally distinct endothelial cell populations. Circulation 140, 147\u2013163 (2019).","journal-title":"Circulation"},{"key":"33202_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"33202_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.10102","volume":"46","author":"MC Blades","year":"2002","unstructured":"Blades, M. C. et al. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum. 46, 824\u2013836 (2002).","journal-title":"Arthritis Rheum."},{"key":"33202_CR29","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.celrep.2020.01.047","volume":"30","author":"J Giri","year":"2020","unstructured":"Giri, J., Das, R., Nylen, E., Chinnadurai, R. & Galipeau, J. CCL2 and CXCL12 derived from mesenchymal stromal cells cooperatively polarize IL-10+ tissue macrophages to mitigate gut injury. Cell Rep. 30, 1923\u20131934.e1924 (2020).","journal-title":"Cell Rep."},{"key":"33202_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1084\/jem.20051772","volume":"203","author":"S Massberg","year":"2006","unstructured":"Massberg, S. et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203, 1221\u20131233 (2006).","journal-title":"J. Exp. Med."},{"key":"33202_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood-2009-12-258186","volume":"117","author":"L Sanchez-Martin","year":"2011","unstructured":"Sanchez-Martin, L. et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 117, 88\u201397 (2011).","journal-title":"Blood"},{"key":"33202_CR32","doi-asserted-by":"publisher","first-page":"6042162","DOI":"10.1155\/2016\/6042162","volume":"2016","author":"L Fang","year":"2016","unstructured":"Fang, L. et al. PPARgene: a database of experimentally verified and computationally predicted PPAR target genes. PPAR Res. 2016, 6042162 (2016).","journal-title":"PPAR Res."},{"key":"33202_CR33","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1161\/ATVBAHA.120.314789","volume":"40","author":"K Xu","year":"2020","unstructured":"Xu, K. et al. Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease. Arterioscler. Thromb. Vasc. Biol. 40, 2910\u20132921 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR34","doi-asserted-by":"publisher","first-page":"19649","DOI":"10.1074\/jbc.M200743200","volume":"277","author":"G Lee","year":"2002","unstructured":"Lee, G. et al. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J. Biol. Chem. 277, 19649\u201319657 (2002).","journal-title":"J. Biol. Chem."},{"key":"33202_CR35","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-19-0270","volume":"9","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. Polyunsaturated fatty acids from astrocytes activate PPARgamma signaling in cancer cells to promote brain metastasis. Cancer Discov. 9, 1720\u20131735 (2019).","journal-title":"Cancer Discov."},{"key":"33202_CR36","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/ATVBAHA.120.314360","volume":"40","author":"MA Raddatz","year":"2020","unstructured":"Raddatz, M. A. et al. Macrophages promote aortic valve cell calcification and alter STAT3 splicing. Arterioscler. Thromb. Vasc. Biol. 40, e153\u2013e165 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.119.042391","volume":"141","author":"AJ Kim","year":"2020","unstructured":"Kim, A. J. et al. Deficiency of circulating monocytes ameliorates the progression of myxomatous valve degeneration in marfan syndrome. Circulation 141, 132\u2013146 (2020).","journal-title":"Circulation"},{"key":"33202_CR38","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.immuni.2018.12.009","volume":"49","author":"HY Lim","year":"2018","unstructured":"Lim, H. Y. et al. Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49, 1191 (2018).","journal-title":"Immunity"},{"key":"33202_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tem.2013.11.001","volume":"25","author":"D Mehrotra","year":"2014","unstructured":"Mehrotra, D., Wu, J., Papangeli, I. & Chun, H. J. Endothelium as a gatekeeper of fatty acid transport. Trends Endocrinol. Metab. 25, 99\u2013106 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"33202_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2014.05.933","volume":"235","author":"S Syvaranta","year":"2014","unstructured":"Syvaranta, S. et al. Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis. Atherosclerosis 235, 398\u2013407 (2014).","journal-title":"Atherosclerosis"},{"key":"33202_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nsmb.1474","volume":"15","author":"T Itoh","year":"2008","unstructured":"Itoh, T. et al. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 15, 924\u2013931 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"33202_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian, M. et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557\u2013566 (2013).","journal-title":"Nat. Med."},{"key":"33202_CR43","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1194\/jlr.R400010-JLR200","volume":"45","author":"AC Li","year":"2004","unstructured":"Li, A. C. & Glass, C. K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45, 2161\u20132173 (2004).","journal-title":"J. Lipid Res."},{"key":"33202_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla, A. et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7, 161\u2013171 (2001).","journal-title":"Mol. Cell"},{"key":"33202_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.ATV.0000103951.67680.B1","volume":"24","author":"M Ricote","year":"2004","unstructured":"Ricote, M., Valledor, A. F. & Glass, C. K. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 230\u2013239 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-2275(20)30159-0","volume":"43","author":"R Walczak","year":"2002","unstructured":"Walczak, R. & Tontonoz, P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J. Lipid Res. 43, 177\u2013186 (2002).","journal-title":"J. Lipid Res."},{"key":"33202_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/ATVBAHA.112.300794","volume":"33","author":"Y Chu","year":"2013","unstructured":"Chu, Y. et al. Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 33, 523\u2013532 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/ATVBAHA.109.198549","volume":"30","author":"MA Guerraty","year":"2010","unstructured":"Guerraty, M. A. et al. Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma pathway activation in swine aortic valve endothelium. Arterioscler. Thromb. Vasc. Biol. 30, 225\u2013231 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan, S. Z., Usher, M. G. & Mortensen, R. M. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ. Res. 102, 283\u2013294 (2008).","journal-title":"Circ. Res."},{"key":"33202_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2270","volume":"3","author":"Y Hou","year":"2012","unstructured":"Hou, Y., Moreau, F. & Chadee, K. PPARgamma is an E3 ligase that induces the degradation of NFkappaB\/p65. Nat. Commun. 3, 1300 (2012).","journal-title":"Nat. Commun."},{"key":"33202_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","volume":"437","author":"G Pascual","year":"2005","unstructured":"Pascual, G. et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759\u2013763 (2005).","journal-title":"Nature"},{"key":"33202_CR52","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4070\/kcj.2017.0029","volume":"48","author":"EH Choo","year":"2018","unstructured":"Choo, E. H. et al. Effect of pioglitazone in combination with moderate dose statin on atherosclerotic inflammation: randomized controlled clinical trial using serial FDG-PET\/CT. Korean Circ. J. 48, 591\u2013601 (2018).","journal-title":"Korean Circ. J."},{"key":"33202_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jacc.2006.08.054","volume":"49","author":"M Hanefeld","year":"2007","unstructured":"Hanefeld, M. et al. Anti-inflammatory effects of pioglitazone and\/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. J. Am. Coll. Cardiol. 49, 290\u2013297 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR54","first-page":"364310","volume":"2011","author":"KL Sider","year":"2011","unstructured":"Sider, K. L., Blaser, M. C. & Simmons, C. A. Animal models of calcific aortic valve disease. Int. J. Inflam. 2011, 364310 (2011).","journal-title":"Int. J. Inflam."},{"key":"33202_CR55","doi-asserted-by":"publisher","first-page":"30427","DOI":"10.1074\/jbc.273.46.30427","volume":"273","author":"DA Towler","year":"1998","unstructured":"Towler, D. A., Bidder, M., Latifi, T., Coleman, T. & Semenkovich, C. F. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273, 30427\u201330434 (1998).","journal-title":"J. Biol. Chem."},{"key":"33202_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.106.654913","volume":"115","author":"E Aikawa","year":"2007","unstructured":"Aikawa, E. et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115, 377\u2013386 (2007).","journal-title":"Circulation"},{"key":"33202_CR57","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.yjmcc.2009.08.008","volume":"47","author":"V Nigam","year":"2009","unstructured":"Nigam, V. & Srivastava, D. Notch1 represses osteogenic pathways in aortic valve cells. J. Mol. Cell Cardiol. 47, 828\u2013834 (2009).","journal-title":"J. Mol. Cell Cardiol."},{"key":"33202_CR58","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/ATVBAHA.111.227561","volume":"31","author":"M Nus","year":"2011","unstructured":"Nus, M. et al. Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK\/CSL. Arterioscler. Thromb. Vasc. Biol. 31, 1580\u20131588 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"33202_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10557-016-6648-3","volume":"30","author":"F Kronenberg","year":"2016","unstructured":"Kronenberg, F. Human genetics and the causal role of lipoprotein(a) for various diseases. Cardiovasc. Drugs Ther. 30, 87\u2013100 (2016).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"33202_CR60","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","volume":"49","author":"C Bergmark","year":"2008","unstructured":"Bergmark, C. et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J. Lipid Res. 49, 2230\u20132239 (2008).","journal-title":"J. Lipid Res."},{"key":"33202_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","volume":"132","author":"R Bouchareb","year":"2015","unstructured":"Bouchareb, R. et al. Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve. Circulation 132, 677\u2013690 (2015).","journal-title":"Circulation"},{"key":"33202_CR62","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","volume":"66","author":"R Capoulade","year":"2015","unstructured":"Capoulade, R. et al. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J. Am. Coll. Cardiol. 66, 1236\u20131246 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","volume":"63","author":"PR Kamstrup","year":"2014","unstructured":"Kamstrup, P. R., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J. Am. Coll. Cardiol. 63, 470\u2013477 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR64","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1109034","volume":"368","author":"G Thanassoulis","year":"2013","unstructured":"Thanassoulis, G. et al. Genetic associations with valvular calcification and aortic stenosis. N. Engl. J. Med. 368, 503\u2013512 (2013).","journal-title":"N. Engl. J. Med."},{"key":"33202_CR65","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","volume":"73","author":"KH Zheng","year":"2019","unstructured":"Zheng, K. H. et al. Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis. J. Am. Coll. Cardiol. 73, 2150\u20132162 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33202_CR66","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCRESAHA.114.302937","volume":"114","author":"MM Bjorklund","year":"2014","unstructured":"Bjorklund, M. M. et al. Induction of atherosclerosis in mice and hamsters without germline genetic engineering. Circ. Res. 114, 1684\u20131689 (2014).","journal-title":"Circ. Res."},{"key":"33202_CR67","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"33202_CR68","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"33202_CR69","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv, https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"33202_CR70","doi-asserted-by":"crossref","unstructured":"Gould, R. A. & Butcher, J. T. Isolation of valvular endothelial cells. J. Vis. Exp. 2158 (2010).","DOI":"10.3791\/2158"},{"key":"33202_CR71","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.celrep.2019.04.102","volume":"27","author":"SW Lukowski","year":"2019","unstructured":"Lukowski, S. W. et al. Single-cell transcriptional profiling of aortic endothelium identifies a hierarchy from endovascular progenitors to differentiated cells. Cell Rep. 27, 2748\u20132758.e2743 (2019).","journal-title":"Cell Rep."},{"key":"33202_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka, J. et al. Single-cell transcriptome atlas of murine endothelial cells. Cell 180, 764\u2013779.e720 (2020).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33202-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33202-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T12:04:59Z","timestamp":1663416299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33202-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33202"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33202-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5461"}}